Hendersonville, North Carolina Clinical Trials

A listing of Hendersonville, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 38 clinical trials
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

This phase III trial studies how well vitamin D3 given with standard chemotherapy and bevacizumab works in treating patients with colorectal cancer that has spread to other parts of the body. Vitamin D3 helps the body use calcium and phosphorus to make strong bones and teeth. Drugs used in chemotherapy, …

fluorouracil
metastatic colorectal adenocarcinoma
adjuvant therapy
major surgery
tumor cells
Margaret R Pardee Memorial Hospital
 (2.3 away) Contact site
  • 72 views
  • 27 Jul, 2021
  • +978 other locations
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)

This is a variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma inadequately controlled with standard of care.

Research Site
 (2.3 away) Contact site
  • 0 views
  • 21 Jul, 2021
  • +227 other locations
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

carcinoma
crizotinib
squamous cell carcinoma
pemetrexed
tumor cells
Margaret R Pardee Memorial Hospital
 (2.3 away) Contact site
  • 1103 views
  • 04 Aug, 2021
  • +1138 other locations
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

This phase III trial studies combination chemotherapy and atezolizumab to see how well it works compared with combination chemotherapy alone in treating patients with stage III colon cancer and deficient deoxyribonucleic acid (DNA) mismatch repair. Drugs used in combination chemotherapy, such as oxaliplatin, leucovorin calcium, and fluorouracil, work in different …

hiv viral load
mmr protein
leucovorin
calcium
monoclonal antibody therapy
Margaret R Pardee Memorial Hospital
 (2.3 away) Contact site
  • 1047 views
  • 01 Aug, 2021
  • +589 other locations
Cediranib Maleate and Olaparib or Standard Chemotherapy in Treating Patients With Recurrent Platinum-Resistant or -Refractory Ovarian Fallopian Tube or Primary Peritoneal Cancer

This randomized phase II/III trial studies how well cediranib maleate and olaparib work when given together or separately, and compares them to standard chemotherapy in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that has returned (recurrent) after receiving chemotherapy with drugs that contain platinum (platinum-resistant) or continued …

carcinoma
vascular endothelial growth factor
olaparib
cediranib
primary peritoneal carcinoma
Margaret R Pardee Memorial Hospital
 (2.3 away) Contact site
  • 1729 views
  • 02 Aug, 2021
  • +211 other locations
A Phase II/III Trial of Nivolumab Ipilimumab and GM-CSF in Patients With Advanced Melanoma

This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may …

nitrosoureas
monoclonal antibody therapy
diabetes
ipilimumab
metastatic melanoma
Margaret R Pardee Memorial Hospital
 (3.3 away) Contact site
  • 46 views
  • 04 Aug, 2021
  • +430 other locations
Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer

This phase III trial studies how well pembrolizumab works in treating patients with bladder cancer that has spread into the deep muscle of the bladder wall (muscle-invasive) or urothelial cancer that has spread from where it started to nearby tissue or lymph nodes (locally advanced). Monoclonal antibodies recognizing and blocking …

AdventHealth Hendersonville
 (2.2 away) Contact site
  • 836 views
  • 04 Aug, 2021
  • +758 other locations
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial enrolls participants for …

human immunodeficiency virus
seminoma
cholangiocarcinoma
adrenal tumor
somatostatin
Margaret R Pardee Memorial Hospital
 (2.3 away) Contact site
  • 6047 views
  • 04 Aug, 2021
  • +814 other locations
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy

This randomized phase III trial studies how well olanzapine with or without fosaprepitant work in preventing chemotherapy induced nausea and vomiting in cancer patients receiving chemotherapy that causes vomiting. Olanzapine and fosaprepitant dimeglumine may help control nausea and vomiting in patients during chemotherapy. Olanzapine is usually given in combination with …

nausea
diabetes
bilateral oophorectomy
cyclophosphamide
primary cancer
AdventHealth Hendersonville
 (5.0 away) Contact site
  • 109 views
  • 29 Jul, 2021
  • +603 other locations
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

This phase III trial studies whether pembrolizumab alone as a first-line treatment, followed by pemetrexed and carboplatin with or without pembrolizumab after disease progression is superior to induction with pembrolizumab, pemetrexed and carboplatin followed by pembrolizumab and pemetrexed maintenance in treating patients with stage IV non-squamous non-small cell lung cancer. …

aptt
leptomeningeal disease
chronic hepatitis b
international normalized ratio
pemetrexed
Margaret R Pardee Memorial Hospital
 (3.3 away) Contact site
  • 208 views
  • 04 Aug, 2021
  • +831 other locations